Rationale and early outcomes for the management of thymoma with proton therapy

od Zhu, He J., Hoppe, Bradford S., Flampouri, Stella, Louis, Debbie, Pirris, John, Nichols, R. Charles, Henderson, Randal H., Mercado, Catherine E.
Wydane w Transl Lung Cancer Res (2018)

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?

od Bryant, Curtis, Mendenhall, Nancy P., Henderson, Randal H., Nichols, Romaine C., Mendenhall, William M., Morris, Christopher G., Williams, Christopher, Su, Zhong, Li, Zuofeng, Hoppe, Bradford S.
Wydane w Am J Clin Oncol (2016)

Circulating Cell-Free DNA Correlates with Body Integral Dose and Radiation Modality in Prostate Cancer

od Lockney, Natalie A., Henderson, Randal, Swarts, Steven G., Zhang, Zhenhuan, Zhang, Bingrong, Li, Jennifer, Zlotecki, Robert A., Morris, Christopher G., Casey-Sawicki, Katherine, Okunieff, Paul
Wydane w Int J Part Ther (2020)

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger

od Hoppe, Bradford S, Nichols, Romaine C, Henderson, Randal H, Morris, Christopher G, Williams, Christopher R, Costa, Joseph, Marcus, Robert B, Mendenhall, William M, Li, Zuofeng, Mendenhall, Nancy P
Wydane 2012

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials

od Henderson, Randal H., Hoppe, Bradford S., Marcus, Robert B., Mendenhall, William M., Nichols, R. Charles, Li, Zuofeng, Su, Zhong, Morris, Christopher G., Williams, Christopher R., Costa, Joseph, Mendenhall, Nancy P.
Wydane 2013

Race Does Not Affect Tumor Control, Adverse Effects, or Quality of Life after Proton Therapy

od Bryant, Curtis, Hoppe, Bradford S., Henderson, Randal H., Nichols, Romaine C., Mendenhall, William M., Smith, Tamara L., Morris, Christopher G., Williams, Christopher R., Su, Zhong, Li, Zuofeng, Mendenhall, Nancy P.
Wydane w Int J Part Ther (2017)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression

od Kil, Whoon Jong, Nichols, Romaine C., Hoppe, Bradford S., Morris, Christopher G., Marcus, Robert B., Mendenhall, William, Mendenhall, Nancy P., Li, Zuofeng, Costa, Joseph A., Williams, Christopher R., Henderson, Randal H.
Wydane 2013

Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate Cancer

od Lee, Derek T., Mendenhall, Nancy P., Smith, Tamara L., Morris, Christopher G., Nichols, Romaine C., Bryant, Curtis, Henderson, Randal H., Mendenhall, William M., Costa, Joseph, Williams, Christopher R., Li, Zuofeng, Hoppe, Bradford S.
Wydane w Int J Part Ther (2016)

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy

od Kharod, Shivam M., Mercado, Catherine E., Morris, Christopher G., Bryant, Curtis M., Mendenhall, Nancy P., Mendenhall, William M., Nichols, R. Charles, Hoppe, Bradford S., Liang, Xiaoying, Su, Zhong, Li, Zuofeng, Henderson, Randal H.
Wydane w Int J Part Ther (2021)

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study

od Kharod, Shivam M., Nichols, R. Charles, Henderson, Randal H., Morris, Christopher G., Pham, Dat C., Seeram, Vandana K., Jones, Lisa M., Antonio-Miranda, Maria, Siragusa, Daniel A., Li, Zuofeng, Flampouri, Stella, Hoppe, Bradford S.
Wydane w Int J Part Ther (2020)

Bacterial Urinary Tract Infection after Transrectal Placement of Fiducial Markers prior to Proton Radiotherapy for Prostate Cancer

od Mendenhall, William M., Glassman, Gabriella, Morris, Christopher G., Costa, Joseph A., Williams, Christopher R., Harris, Stephanie E., Mandia, Stephen E., Hoppe, Bradford S., Henderson, Randal H., Bryant, Curtis M., Nichols, R. Charles, Mendenhall, Nancy P.
Wydane w Int J Part Ther (2016)

Comparative Effectiveness Study of Patient-Reported Outcomes following Proton Therapy or IMRT for Prostate Cancer

od Hoppe, Bradford S., Michalski, Jeff M., Mendenhall, Nancy P., Morris, Christopher G., Henderson, Randal H., Nichols, Romaine C., Mendenhall, William M., Williams, Christopher, Regan, Meredith M., Chipman, Jonathan, Crociani, Catrina, Sandler, Howard M., Sanda, Martin G., Hamstra, Daniel A.
Wydane 2013